Anti-PDLIM1 monoclonal antibody
Pre-made anti-PDLIM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to PDLIM1/PDLIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2649-Ab-1/ GM-Tg-hg-IP2649-Ab-2 | Anti-Human PDLIM1 monoclonal antibody | Human |
GM-Tg-rg-IP2649-Ab-1/ GM-Tg-rg-IP2649-Ab-2 | Anti-Rat PDLIM1 monoclonal antibody | Rat |
GM-Tg-mg-IP2649-Ab-1/ GM-Tg-mg-IP2649-Ab-2 | Anti-Mouse PDLIM1 monoclonal antibody | Mouse |
GM-Tg-cynog-IP2649-Ab-1/ GM-Tg-cynog-IP2649-Ab-2 | Anti-Cynomolgus/ Rhesus macaque PDLIM1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2649-Ab-1/ GM-Tg-felg-IP2649-Ab-2 | Anti-Feline PDLIM1 monoclonal antibody | Feline |
GM-Tg-cang-IP2649-Ab-1/ GM-Tg-cang-IP2649-Ab-2 | Anti-Canine PDLIM1 monoclonal antibody | Canine |
GM-Tg-bovg-IP2649-Ab-1/ GM-Tg-bovg-IP2649-Ab-2 | Anti-Bovine PDLIM1 monoclonal antibody | Bovine |
GM-Tg-equg-IP2649-Ab-1/ GM-Tg-equg-IP2649-Ab-2 | Anti-Equine PDLIM1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2649-Ab-1/ GM-Tg-hg-IP2649-Ab-2; GM-Tg-rg-IP2649-Ab-1/ GM-Tg-rg-IP2649-Ab-2; GM-Tg-mg-IP2649-Ab-1/ GM-Tg-mg-IP2649-Ab-2; GM-Tg-cynog-IP2649-Ab-1/ GM-Tg-cynog-IP2649-Ab-2; GM-Tg-felg-IP2649-Ab-1/ GM-Tg-felg-IP2649-Ab-2; GM-Tg-cang-IP2649-Ab-1/ GM-Tg-cang-IP2649-Ab-2; GM-Tg-bovg-IP2649-Ab-1/ GM-Tg-bovg-IP2649-Ab-2; GM-Tg-equg-IP2649-Ab-1/ GM-Tg-equg-IP2649-Ab-2 |
Products Name | Anti-PDLIM1 monoclonal antibody |
Format | mab |
Target Name | PDLIM1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-PDLIM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2649-Ag-1 | Recombinant multi-species PDLI1/ PDLIM1/ CLIM1 protein |
ORF Viral Vector | pGMLP004300 | human PDLIM1 Lentivirus plasmid |
ORF Viral Vector | vGMLP004300 | human PDLIM1 Lentivirus particle |
ORF Viral Vector | pGMLPm003217 | mouse Pdlim1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm003217 | mouse Pdlim1 Lentivirus particle |
Target information
Target ID | GM-IP2649 |
Target Name | PDLIM1 |
Gene ID | 9124,54132,54133,702998,477779,101095859,614675,100061326 |
Gene Symbol and Synonyms | CLIM1,CLP-36,CLP36,hCLIM1,HEL-S-112,mClim1,PDLIM1 |
Uniprot Accession | O00151,P52944,Q5E9E1 |
Uniprot Entry Name | PDLI1_HUMAN,PDLI1_RAT,PDLI1_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000107438 |
Target Classification | N/A |
The target: PDLIM1, gene name: PDLIM1, also named as CLIM1, CLP-36, CLP36, HEL-S-112, hCLIM1. This gene encodes a member of the enigma protein family. The protein contains two protein interacting domains, a PDZ domain at the amino terminal end and one to three LIM domains at the carboxyl terminal. It is a cytoplasmic protein associated with the cytoskeleton. The protein may function as an adapter to bring other LIM-interacting proteins to the cytoskeleton. Pseudogenes associated with this gene are located on chromosomes 3, 14 and 17. [provided by RefSeq, Oct 2012].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.